Matinas BioPharma Holdings, Inc. (MTNB)
0.1821
0.00 (0.00%)
USD |
NYAM |
Sep 09, 09:59
Matinas BioPharma Holdings Price to Book Value : 0.6481 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.6477 |
| September 04, 2026 | 0.6477 |
| September 03, 2026 | 0.6442 |
| September 02, 2026 | 0.662 |
| September 01, 2026 | 0.7036 |
| August 31, 2026 | 0.7036 |
| August 28, 2026 | 0.7118 |
| August 27, 2026 | 0.7118 |
| August 26, 2026 | 0.699 |
| August 25, 2026 | 0.7022 |
| August 24, 2026 | 0.6993 |
| August 21, 2026 | 0.7075 |
| August 20, 2026 | 0.6495 |
| August 19, 2026 | 0.8577 |
| August 18, 2026 | 0.725 |
| August 17, 2026 | 0.7908 |
| August 14, 2026 | 0.8328 |
| August 13, 2026 | 0.8292 |
| August 12, 2026 | 0.8542 |
| August 11, 2026 | 0.9325 |
| August 10, 2026 | 0.9574 |
| August 07, 2026 | 1.007 |
| August 06, 2026 | 0.9552 |
| August 05, 2026 | 0.9787 |
| August 04, 2026 | 1.034 |
| Date | Value |
|---|---|
| August 03, 2026 | 1.073 |
| July 31, 2026 | 1.046 |
| July 30, 2026 | 1.130 |
| July 29, 2026 | 1.060 |
| July 28, 2026 | 1.043 |
| July 27, 2026 | 1.182 |
| July 24, 2026 | 0.8591 |
| July 23, 2026 | 0.8869 |
| July 22, 2026 | 0.951 |
| July 21, 2026 | 0.9979 |
| July 20, 2026 | 1.12 |
| July 17, 2026 | 1.223 |
| July 16, 2026 | 1.269 |
| July 15, 2026 | 1.213 |
| July 14, 2026 | 1.245 |
| July 13, 2026 | 1.708 |
| July 10, 2026 | 2.688 |
| July 09, 2026 | 2.232 |
| July 08, 2026 | 2.192 |
| July 07, 2026 | 2.210 |
| July 06, 2026 | 2.235 |
| July 02, 2026 | 2.255 |
| July 01, 2026 | 2.245 |
| June 30, 2026 | 2.178 |
| June 29, 2026 | 1.408 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.660 |
| Alnylam Pharmaceuticals, Inc. | 25.52 |
| Anika Therapeutics, Inc. | 2.071 |
| Savara, Inc. | 7.807 |
| Vericel Corp. | 5.379 |
Price to Book Value Related Metrics
| Price | 0.1821 |
| Earnings Yield | -659.5% |
| Market Cap | 1.167M |